; and (ii) the total number of units of the insulin product which were sold in commerce in such calendar year. (C) Adjustment amount The term adjustment amount means the amount, if any, of the gross price spike revenue which the Inspector General has determined is due solely to an increase in the cost of the inputs necessary to manufacture the insulin product subject to the price spike. (b) Submission by pharmaceutical companies of information to Inspector General (1) In general For each insulin product, the applicable entity shall submit to the Inspector General a quarterly report that includes each of the following: (A) For each insulin product of the applicable entity— (i) the total number of units of the insulin product which were sold in commerce in the preceding calendar quarter; (ii) the average and median wholesale acquisition cost per unit of such insulin product in commerce in the preceding calendar quarter, disaggregated by month